Product
Blood Glucose
2 clinical trials
5 indications
Indication
HypoglycemiaIndication
NeonatalIndication
PretermIndication
Glibenclamide adverse reactionIndication
Type 1 DiabetesClinical trial
Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)Status: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
Characterization of Autoreactive Regulatory and Conventional CD4 T Cells in Recent Onset Type 1 Diabetes and Control IndividualsStatus: Not yet recruiting, Estimated PCD: 2026-08-01